CINECA IRIS Institutional Research Information System

DE FRANCIA, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.172
EU - Europa 7.307
AS - Asia 6.288
SA - Sud America 910
Continente sconosciuto - Info sul continente non disponibili 777
AF - Africa 173
OC - Oceania 62
Totale 26.689
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.833
IT - Italia 2.795
SG - Singapore 2.447
CN - Cina 1.463
BR - Brasile 674
DE - Germania 645
VN - Vietnam 630
SE - Svezia 555
FR - Francia 551
IE - Irlanda 453
KR - Corea 415
FI - Finlandia 327
DK - Danimarca 324
JP - Giappone 302
IN - India 285
GB - Regno Unito 258
UA - Ucraina 237
HK - Hong Kong 179
CA - Canada 178
AT - Austria 172
PL - Polonia 153
NL - Olanda 150
ES - Italia 132
LU - Lussemburgo 132
RU - Federazione Russa 96
BD - Bangladesh 87
AR - Argentina 85
ID - Indonesia 82
MX - Messico 71
IQ - Iraq 68
AU - Australia 55
TR - Turchia 53
BE - Belgio 51
GR - Grecia 42
CZ - Repubblica Ceca 41
PK - Pakistan 38
CO - Colombia 37
ZA - Sudafrica 37
CL - Cile 34
EC - Ecuador 34
CH - Svizzera 30
JM - Giamaica 28
SN - Senegal 28
TW - Taiwan 28
TH - Thailandia 27
EG - Egitto 25
PT - Portogallo 25
JO - Giordania 24
IR - Iran 21
DZ - Algeria 20
MA - Marocco 20
LT - Lituania 19
VE - Venezuela 19
CR - Costa Rica 18
SI - Slovenia 18
HR - Croazia 16
PH - Filippine 15
UZ - Uzbekistan 15
HU - Ungheria 14
RS - Serbia 14
MY - Malesia 12
SA - Arabia Saudita 12
IL - Israele 11
KZ - Kazakistan 11
ET - Etiopia 10
PE - Perù 10
PY - Paraguay 9
RO - Romania 9
TN - Tunisia 9
SY - Repubblica araba siriana 8
AZ - Azerbaigian 7
BY - Bielorussia 7
LV - Lettonia 7
NG - Nigeria 7
NZ - Nuova Zelanda 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
BG - Bulgaria 6
MU - Mauritius 6
NO - Norvegia 6
BB - Barbados 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
HN - Honduras 5
LB - Libano 5
NP - Nepal 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
BH - Bahrain 4
EU - Europa 4
KE - Kenya 4
KW - Kuwait 4
NI - Nicaragua 4
OM - Oman 4
PS - Palestinian Territory 4
A1 - Anonimo 3
AL - Albania 3
EE - Estonia 3
GE - Georgia 3
MK - Macedonia 3
Totale 25.875
Salva come PNG Salva come JPEG
Città #
Singapore 1.430
Ashburn 915
Chandler 891
Ann Arbor 770
San Jose 692
Santa Clara 630
Beijing 619
Dublin 437
Turin 424
Milan 314
Fairfield 299
Torino 284
Houston 279
Dallas 226
Los Angeles 221
Nyköping 201
Hefei 192
Council Bluffs 190
Seoul 190
Ho Chi Minh City 174
Wilmington 170
The Dalles 169
Rome 164
Columbus 163
New York 152
Woodbridge 147
Vienna 145
Lauterbourg 144
Villeurbanne 144
Hong Kong 142
Redwood City 139
Jacksonville 138
Seattle 137
Munich 135
Tokyo 127
Dearborn 125
Hanoi 125
Medford 124
Princeton 122
Cambridge 115
Helsinki 113
Warsaw 112
Buffalo 97
São Paulo 76
Pisa 72
Dudelange 66
Luxembourg 65
Dong Ket 64
Bengaluru 61
Boston 59
Fremont 58
Düsseldorf 54
Jakarta 53
London 50
Florence 48
Guangzhou 47
Boardman 44
Frankfurt am Main 44
Shanghai 43
Orem 41
Toronto 41
Verona 41
Bologna 38
Turku 37
Brooklyn 36
Brussels 36
Chicago 36
Nuremberg 36
Paris 36
Phoenix 35
Atlanta 34
Montreal 33
Da Nang 31
Padova 31
Mumbai 30
West Jordan 30
Würzburg 30
Naples 28
Redondo Beach 28
Brno 27
Chennai 27
Rio de Janeiro 27
Mexico City 25
Denver 24
Haiphong 24
Manchester 24
Nanjing 24
Amsterdam 23
Baghdad 23
Bari 23
Johannesburg 23
Memphis 23
San Diego 23
Catania 22
Amman 21
Hangzhou 21
Madrid 21
Palermo 21
Falkenstein 20
Philadelphia 20
Totale 14.605
Salva come PNG Salva come JPEG
Nome #
Practical treatment using mitotane for adrenocortical carcinoma. 872
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 589
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. 537
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children 504
MITOTANE LEVELS PREDICT THE OUTCOME OF PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION. 470
Management of adjuvant mitotane therapy following resection of adrenal cancer. 431
La Medicina delle differenze. Storie di donne, uomini e discriminazioni. 401
Steroid resistance in nasal polyposis: role of glucocorticoid receptor and TGF-beta1. 375
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC). 363
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 360
Subchronic nandrolone administration reduces cardiac oxidative markers during restraint stress by modulating protein expression patterns. 346
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 339
A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. 304
Effects of sub-chronic nandrolone administration on hormonal adaptive response to acute stress in rats. 295
Malattia di Alzheimer: prototipo di malattia di genere? 262
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment 262
Single-Nucleotide Polymorphisms of ABCB1 Gene Influence Intracellular Concentrations of Dasatinib. 251
GENDER-SPECIFIC SIDE EFFECTS OF CHEMOTHERAPY IN PANCREATIC CANCER PATIENTS 251
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients 250
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 248
PHARMACOGENETIC DETERMINANTS OF PLASMATIC AND INTRACELLULAR TYROSINE KINASE INHIBITORS 242
Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines 233
Intense physical exercise increases systemic 11b-hydroxysteroid dehydrogenase type 1 activity in healty adult subjects 232
Procedimento cromatografico di dosaggio di DDT, DDD, DDA, e DDE 228
Role of pharmacogenetics on deferasirox AUC and efficacy 226
"Procedimento per determinare glifosato e acido aminometilfosfonico in un campione" 225
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia 224
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection 221
11betahydroxysteroid dehydrogenase type 1 and 2 activities in bone fragments of patients with rheumatoid arthritis 219
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 218
Il diritto alla scienza medica e le questioni di genere in Così San Tuttə. Diritto alla scienza: istruzioni per l’uso. 217
La recidiva di carcinoma del cortico-surrene:trattamento chirurgico o chemioterapico? 216
Biological and molecular effects of high doses of anabolic steroids 216
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia 216
“La salute è un diritto di genere" 207
New hplc-mass spectrometry method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib, and nilotinib 206
Role of Cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use 203
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008 202
Differential patterns of glucocorticoid receptors and 11beta hydroxysteroid dehydrogenase activity in androgen-dependent and androgen-independent prostate cancer cell lines. Relevance to glucocorticoid sensitivity. 198
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 197
A prospective study on adjuvant mitotane 190
In vitro enhancement of anticancer activity of paclitaxel by a Cremophor free cyclodextrin-based nanosponge formulation 185
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 185
Efficacia del reintervento chirurgico in pazienti con carcinoma del cortico-surrene recidivo 184
Short QT syndrome in infancy. Therapeutic drug monitoring of hydroquinidine in a newborn infant. 181
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants 177
Role of cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use 172
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children 170
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 169
GENDER ANALYSIS ON COVID-19 DATA IN PIEMONTE: THE VIRUS PREFERS MEN 169
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness. 168
Efficacy of repeat surgery in patients with recurrent adrenocortical cancer (ACC) 168
La fluidità dei confini: il diritto alla salute ha un genere? 166
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 164
Clinical relevance of the assessment of deferasirox trough levels in thalassemia patients 164
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma 163
NURR1 deficiency is associated to ADHD-like phenotypes in mice 162
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients 160
Clinical relevance of deferasirox trough levels in β-thalassemia patients 160
Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics 159
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients 154
L'esperienza dell'ospedale san Luigi nel trattamento con mitotane adiuvante in pazienti operati radicalmente per carcinoma corticosurrenalico. 153
Deferasirox AUC efficacy cutoff and role of pharmacogenetics 153
Effects of germline CYP2W1*6 and CYP2B6*6 single nucleotide polymorphisms on mitotane treatment in adrenocortical carcinoma: A multicenter ENSAT study 150
Valutazione prospettica di pazienti operati radicalmente per carcinoma corticosurrenalico in trattamento con mitotane adiuvante: correlazioni tra indici di massa corporea, livelli di mitotanemia ed efficacia. 149
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients 148
Self-Completion Questionnaire on Sleep Evaluation in Patients Undergoing Oxaliplatin Therapy: An Observational Study 146
Cremophor free cyclodextrin-based nanosponge formulation for the delivery of paclitaxel 146
Does nephrectomy during adrenalectomy for adrenal cancer improve oncological results? 146
Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring 146
New Standardized Procedure to Extract Glyphosate and Aminomethylphosphonic Acid from Different Matrices: A Kit for HPLC-UV Detection 145
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness 144
Acute particulate matter (PM10) exposure selectively triggers behavioral alterations in the presymptomatic Experimental Autoimmune Encephalomyelitis (EAE) mouse model of Multiple Sclerosis 143
Efficacia del reintervento chirurgico in pazienti con carcinoma del cortico-surrene recidivo 142
COVID-19 infection: ACE2, pregnancy and preeclampsia 141
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 140
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study. 140
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients 140
DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR OROTIC ACID AND OROTIDINE 5’-MONOPHOSPHATE DETECTION IN HUMAN PLASMA AND URINE 140
Quantification of imatinib plasma levels in patients with chronic myeloid leukemia: Comparison between HPLC-UV and LC-MS/MS 138
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 136
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome 136
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma 135
The San Luigi hospital experience with adjuvant mitotane treatment in patients with adrenocortical cancer following radical resection 135
Hydroxyurea pharmacokinetic evaluation in Sickle Cell Disease patients. 134
Procedimento per determinare glifosato e acido aminometilfosfonico in un campione 131
Determinanti farmacogenetici della farmacocinetica del mitotane: studio condotto su pazienti affetti da carcinoma corticosurrenalico 131
Influence of single nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness: study on beta-talassemia major affected patients 131
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly 130
Sex-tailored pharmacology and COVID-19: next steps towards appropriateness and health equity 129
Pharmacogenetic of voriconazole antifungal agent in pediatric patients 127
A current perspective on treatment of adrenocortical carcinoma 127
The influence of sex, gender and age on COVID-19 data in the Piedmont region: the virus prefers men 127
NURR1-deficient mice have age- and sex-specific behavioral phenotypes 126
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma 126
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 125
EVALUTATION OF THE CONTROL OF PAIN IN PATIENTS WITH BONE METASTASIS UNDERGOING MEDICAL TREATMENT WITH BISPHOSPHONATES 124
EFFECT OF SEASONS ON FOUR ANTI-EPILEPTIC DRUGS PLASMA LEVELS 124
Single nucleotide polymorphisms of ABCB1 gene influence on intracellular concentrations of dasatinib. 123
New hplc–uv validated method for therapeutic drug monitoring of antifungal agents in acute myeloid leukemia 123
Totale 20.956
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.596
article - articoli 0
book - libri 0
conference - conferenze 25.175
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.771
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.014 0 0 134 192 143 166 180 170 105 187 417 320
2022/20232.733 247 267 121 268 235 651 158 174 283 73 178 78
2023/20241.433 162 198 121 77 106 132 54 64 40 132 140 207
2024/20254.057 111 207 183 352 863 288 189 245 427 256 330 606
2025/20268.442 843 491 540 1.095 993 405 1.144 291 727 529 353 1.031
2026/20271.389 435 684 270 0 0 0 0 0 0 0 0 0
Totale 26.689